0001104659-22-070219.txt : 20220610
0001104659-22-070219.hdr.sgml : 20220610
20220610172134
ACCESSION NUMBER: 0001104659-22-070219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOVEN ANDREW I
CENTRAL INDEX KEY: 0001258673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 221009934
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE, SUITE 1710
STREET 2: C/O ARALEZ PHARMACEUTICALS INC.
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
tm2218193-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-09
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001258673
KOVEN ANDREW I
C/O NEUROBO PHARMACEUTICALS, INC.
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON
MA
02116
1
0
0
0
Nonstatutory Stock Option (right to buy)
0.4725
2022-06-09
4
A
0
20000
0
A
2032-06-09
Common Stock
20000
20000
D
Vests on the earlier of June 9, 2023 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.
/s/ Andrew I. Koven
2022-06-10